Prognostic Value of SPECT-imaging Myocardial Perfusion Heterogeneity (EVAPERF)
Primary Purpose
Coronary Artery Disease, Coronary Atherosclerosis
Status
Active
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
Stress Single Photon Emission Computed Tomography
Sponsored by
About this trial
This is an interventional diagnostic trial for Coronary Artery Disease focused on measuring Coronary Circulation, Coronary Artery Disease, Myocardial perfusion imaging, Prognosis
Eligibility Criteria
Inclusion Criteria:
- Age > 18 years
- Clinical indication for myocardial perfusion imaging
Exclusion Criteria:
- Pregnancy
- Breast feeding women
- Severe comorbidity with life expectancy 6 months
- Left bundle branch block on ECG making heteogeneity analysis impossible
- Patient not resident in the Rhône-Alpes region
Sites / Locations
- University Hospital
Arms of the Study
Arm 1
Arm Type
Other
Arm Label
Study cohort
Arm Description
Any patient referred to the Nuclear Cardiology Laboratory of the University Hospital of Grenoble for myocardial perfusion imaging for diagnosis or prognosis evaluation of suspected or know coronary artery disease
Outcomes
Primary Outcome Measures
Major Adverse Cardiac and Cerebrovascular Events (MACCEs)
Composite outcome : cardiac death and/or acute coronary syndrome and/or coronary artery bypass graft and/or percutaneous coronary intervention and/or stroke and/or symptomatic peripheral artery disease
Secondary Outcome Measures
composite secondary outcome : number of cardiac death or nonfatal Myocardial Infarction
composite secondary outcome : number of cardiac death or nonfatal Myocardial Infarction or stroke
composite secondary outcome : number of participants with myocardial revascularization
composite secondary outcome : number of all death or non fatal Myocardial Infarction
composite secondary outcome : number of all death or non fatal Myocardial Infarction or non fatal stroke
composite secondary outcome : number of all death or non fatal Myocardial Infarction or non fatal stroke or number of participants with myocardial revascularization
composite secondary outcome : number of all death or non fatal Myocardial Infarction or non fatal stroke or number of participants with myocardial revascularization or symptomatic peripheral artery disease
peripheral artery disease (intermittent claudication/new episode of critical limb ischaemia, new percutaneous/surgical revascularization, or amputation).
cardiac death
Death from coronary artery disease, heart failure, or sudden death
Non fatal Myocardial Infarction
acute coronary syndrome
Non fatal Stroke
Coronary artery bypass graft and/or percutaneous coronary intervention
14 Symptomatic peripheral artery disease (intermittent claudication/new episode of critical limb ischaemia, new percutaneous/surgical revascularization, or amputation)
influence of air pollution exposure for short and long terms of exposure on myocardial Heterogeneity Index
Air pollution is estimated for each patient thanks to their postal private and professional adresses for different windows of exposure :
short term windows (2hours to 7 days before the MP-SPECT and cardiovascular events).
long term windows (1 - 5 years before the MP-SPECT and before cardiovascular events)
influence of air pollution exposure for short and long terms of exposure on cardiovascular events
Air pollution is estimated for each patient thanks to their postal private and professional adresses for different windows of exposure :
short term windows (2hours to 7 days before the MP-SPECT and cardiovascular events).
long term windows (1 - 5 years before the MP-SPECT and before cardiovascular events)
Full Information
NCT ID
NCT02208765
First Posted
August 4, 2014
Last Updated
May 18, 2022
Sponsor
University Hospital, Grenoble
1. Study Identification
Unique Protocol Identification Number
NCT02208765
Brief Title
Prognostic Value of SPECT-imaging Myocardial Perfusion Heterogeneity
Acronym
EVAPERF
Official Title
Prognostic Value of Myocardial Perfusion Heterogeneity Assessed by Stress Single Photon Emission Computed Tomography
Study Type
Interventional
2. Study Status
Record Verification Date
May 2022
Overall Recruitment Status
Active, not recruiting
Study Start Date
January 2015 (Actual)
Primary Completion Date
June 2022 (Anticipated)
Study Completion Date
June 2022 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University Hospital, Grenoble
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
Endothelial dysfunction has been demonstrated to be an early marker of coronary artery disease (CAD). On the other hand, myocardial perfusion single photon emission computed tomography (MP-SPECT) is a widely used technique for evaluation of patients with suspected or known CAD.
Preliminary data suggest that myocardial perfusion heterogeneity (a potential surrogate marker of endothelial dysfunction) can be assessed on conventional MP-SPECT, but its additive and independent prognostic value over the presence of myocardial ischemia remain unknown.
More over, factual data demonstrate that inhalation of particulate matters and gaz (NO2, CO) from air pollution contributes to the development of cardiovascular diseases in the short and long term. The role of air pollution in endothelial dysfunction has been suggested.
Accordingly, the purpose of this study is to evaluate the prognostic value of myocardial perfusion heterogeneity assessed by a new automatized image processing method applied to routine MP-SPECT.
The second purpose is to evaluate the role of air pollution exposure in pathogenesis of cardiovascular disease.
The main hypothesis is that the presence of myocardial perfusion heterogeneity is predictive of 2-year cardiovascular events in patients referred to the Nuclear Cardiology Department for routine evaluation of known or suspected CAD.
The second hypothesis is that microcirculatory coronary dysfunction is a causal link between air pollution and cardiovascular disease.
Detailed Description
SPECT imaging protocol and analysis Stress tests and SPECTs are performed according to the routine protocols in use in our center. Briefly, at peak stress, patients were injected with thallium-201. Five to 10 minutes after stress, a 5-minutes supine acquisition was performed followed by a 5-minutes prone acquisition. Subsequently, technetium-99m-sestamibi was injected, and 2 minutes later a single 5-minutes rest acquisition was performed. During stress acquisition, patients were imaged in supine and prone positions with their arms positioned over their head. The rest acquisition was only acquired in supine position. The gated SPECT studies were performed at each acquisition. Injected activity (IA) was adjusted for patient weight. For weights of <80 kg/ 80-100 kg/>100 kg, thallium-201 IAs were 74/92/111 MBq and technetium-99m-sestamibi IAs were 300/370/450 MBq, respectively. A uniform imaging pre-treatment for the reconstruction of raw myocardial perfusion imaging data was applied, and images were reconstructed and reoriented to obtain transaxial sections of the left ventricle according to the three standard cardiac planes.
In this study, we use a new mathematic technique from entropy analysis to provide precise, objective, automated quantification of perfusion heterogeneity at stress with camera SPECT. This method may be a non-invasive imaging to assess coronary microvascular dysfunction.
Air pollution exposure (particule matters and gaz) is estimated by SIRANE dispersion models validated by Air Rhône-Alpes, our regional agency tasked with protecting and managing the ambient air quality. The dispersion models are used to estimate the downwind ambient concentration of air pollutants or toxins emitted from sources such as industrial plants, vehicular traffic or accidental chemical releases.
Air pollution is estimated for each patient thanks to their postal private and professional adresses for different windows of exposure :
short term windows (2hours to 7 days before the MP-SPECT and cardiovascular events).
long term windows (1 - 5 years before the MP-SPECT and before cardiovascular events)
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Coronary Artery Disease, Coronary Atherosclerosis
Keywords
Coronary Circulation, Coronary Artery Disease, Myocardial perfusion imaging, Prognosis
7. Study Design
Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
1600 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Study cohort
Arm Type
Other
Arm Description
Any patient referred to the Nuclear Cardiology Laboratory of the University Hospital of Grenoble for myocardial perfusion imaging for diagnosis or prognosis evaluation of suspected or know coronary artery disease
Intervention Type
Device
Intervention Name(s)
Stress Single Photon Emission Computed Tomography
Primary Outcome Measure Information:
Title
Major Adverse Cardiac and Cerebrovascular Events (MACCEs)
Description
Composite outcome : cardiac death and/or acute coronary syndrome and/or coronary artery bypass graft and/or percutaneous coronary intervention and/or stroke and/or symptomatic peripheral artery disease
Time Frame
2 years
Secondary Outcome Measure Information:
Title
composite secondary outcome : number of cardiac death or nonfatal Myocardial Infarction
Time Frame
2 years
Title
composite secondary outcome : number of cardiac death or nonfatal Myocardial Infarction or stroke
Time Frame
2 years
Title
composite secondary outcome : number of participants with myocardial revascularization
Time Frame
2 years
Title
composite secondary outcome : number of all death or non fatal Myocardial Infarction
Time Frame
2 years
Title
composite secondary outcome : number of all death or non fatal Myocardial Infarction or non fatal stroke
Time Frame
2 years
Title
composite secondary outcome : number of all death or non fatal Myocardial Infarction or non fatal stroke or number of participants with myocardial revascularization
Time Frame
2 years
Title
composite secondary outcome : number of all death or non fatal Myocardial Infarction or non fatal stroke or number of participants with myocardial revascularization or symptomatic peripheral artery disease
Description
peripheral artery disease (intermittent claudication/new episode of critical limb ischaemia, new percutaneous/surgical revascularization, or amputation).
Time Frame
2 years
Title
cardiac death
Description
Death from coronary artery disease, heart failure, or sudden death
Time Frame
2 years
Title
Non fatal Myocardial Infarction
Time Frame
2 years
Title
acute coronary syndrome
Time Frame
2 years
Title
Non fatal Stroke
Time Frame
2 years
Title
Coronary artery bypass graft and/or percutaneous coronary intervention
Time Frame
2 years
Title
14 Symptomatic peripheral artery disease (intermittent claudication/new episode of critical limb ischaemia, new percutaneous/surgical revascularization, or amputation)
Time Frame
2 years
Title
influence of air pollution exposure for short and long terms of exposure on myocardial Heterogeneity Index
Description
Air pollution is estimated for each patient thanks to their postal private and professional adresses for different windows of exposure :
short term windows (2hours to 7 days before the MP-SPECT and cardiovascular events).
long term windows (1 - 5 years before the MP-SPECT and before cardiovascular events)
Time Frame
inclusion
Title
influence of air pollution exposure for short and long terms of exposure on cardiovascular events
Description
Air pollution is estimated for each patient thanks to their postal private and professional adresses for different windows of exposure :
short term windows (2hours to 7 days before the MP-SPECT and cardiovascular events).
long term windows (1 - 5 years before the MP-SPECT and before cardiovascular events)
Time Frame
2 years
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Age > 18 years
Clinical indication for myocardial perfusion imaging
Exclusion Criteria:
Pregnancy
Breast feeding women
Severe comorbidity with life expectancy 6 months
Left bundle branch block on ECG making heteogeneity analysis impossible
Patient not resident in the Rhône-Alpes region
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Gerald Vanzetto, MD, PhD
Organizational Affiliation
University Hospital, Grenoble
Official's Role
Principal Investigator
Facility Information:
Facility Name
University Hospital
City
Grenoble
ZIP/Postal Code
38000
Country
France
12. IPD Sharing Statement
Citations:
PubMed Identifier
14581384
Citation
Verma S, Buchanan MR, Anderson TJ. Endothelial function testing as a biomarker of vascular disease. Circulation. 2003 Oct 28;108(17):2054-9. doi: 10.1161/01.CIR.0000089191.72957.ED. No abstract available.
Results Reference
background
PubMed Identifier
15862426
Citation
Schindler TH, Nitzsche EU, Schelbert HR, Olschewski M, Sayre J, Mix M, Brink I, Zhang XL, Kreissl M, Magosaki N, Just H, Solzbach U. Positron emission tomography-measured abnormal responses of myocardial blood flow to sympathetic stimulation are associated with the risk of developing cardiovascular events. J Am Coll Cardiol. 2005 May 3;45(9):1505-12. doi: 10.1016/j.jacc.2005.01.040.
Results Reference
background
PubMed Identifier
10510055
Citation
Vanzetto G, Ormezzano O, Fagret D, Comet M, Denis B, Machecourt J. Long-term additive prognostic value of thallium-201 myocardial perfusion imaging over clinical and exercise stress test in low to intermediate risk patients : study in 1137 patients with 6-year follow-up. Circulation. 1999 Oct 5;100(14):1521-7. doi: 10.1161/01.cir.100.14.1521.
Results Reference
background
PubMed Identifier
16157524
Citation
Johnson NP, Gould KL. Clinical evaluation of a new concept: resting myocardial perfusion heterogeneity quantified by markovian analysis of PET identifies coronary microvascular dysfunction and early atherosclerosis in 1,034 subjects. J Nucl Med. 2005 Sep;46(9):1427-37.
Results Reference
background
Learn more about this trial
Prognostic Value of SPECT-imaging Myocardial Perfusion Heterogeneity
We'll reach out to this number within 24 hrs